SIM0010InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)Add recommended isotype control1mg
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0489802
- Awardee
- Bio X Cell
- Contracting organization
- University of Virginia
- Cumulative value
- $243.00
About this award
The University of Virginia issued purchase order A207_PO-0489802 to Bio X Cell on October 9, 2026, for the procurement of specialized immunological research materials. The contract, valued at $243, represents a single-line item acquisition for one unit of SIM0010 InVivoSIM anti-human programmed death receptor 1 (PD-1) pembrolizumab biosimilar, to be delivered to Amy D Adams at the University of Virginia in Virginia.
The deliverable includes the specified anti-human PD-1 biosimilar product with a recommended isotype control component. This procurement reflects the University of Virginia's acquisition of research-grade immunological agents necessary for in vivo simulation studies, commonly utilized in cancer immunotherapy research and development. The contract was executed in Virginia and represents a direct purchase transaction between the state institution and the vendor for materials delivery.
Line items
| Item | Total |
|---|---|
| SIM0010InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)Add recommended isotype control1mg | $243.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0489802?
Contract A207_PO-0489802 was awarded to Bio X Cell by University of Virginia on October 9, 2026.
How much is contract A207_PO-0489802 worth?
Its cumulative value is $243.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award